REGENXBIO Inc.

NASDAQ: RGNX · Real-Time Price · USD
9.87
0.26 (2.71%)
At close: May 01, 2025, 3:59 PM
9.14
-7.30%
After-hours: May 01, 2025, 05:46 PM EDT

REGENXBIO Revenue

REGENXBIO reported an annual revenue of $83.33M, reflecting a -7.66% growth. For the quarter ending December 31, 2024, REGENXBIO generated $21.21M in revenue.
Revenue (ttm)
$83.33M
Revenue Growth
-7.66%
Price / Sales Ratio
4.59
Revenue / Employee
$236.06K
Employees
353
Market Cap
494.4M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 83.33M -7.66%
Dec 31, 2023 90.24M -19.94%
Dec 31, 2022 112.72M -76.03%
Dec 31, 2021 470.35M +204.30%
Dec 31, 2020 154.57M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.